
William W. O'Neill, MD, FACC
Chief Medical Officer & Senior Principal Investigator
Pioneer of transcatheter aortic valve replacement (TAVR) in the United States. National Principal Investigator on Edwards PARTNER, Protect II, and Protect IV. Founder of the National Cardiogenic Shock Initiative. 45+ years of cardiovascular medicine experience.
Specialties
- Structural heart disease
- TAVR & transcatheter valve therapy
- High-risk PCI & cardiogenic shock
- Pivotal device trial leadership









